What is Tyra Biosciences, Inc.'s preferred stock?

Tyra Biosciences, Inc. (TYRA) reported preferred stock of $0 in Q1 2026.

What does preferred stock mean?

Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.

Tyra Biosciences, Inc. TYRA Preferred Stock

Preferred Stock at other companies

IncyteINCY

$0—

BridgeBio PharmaBBIO

$0—

Syndax PharmaceuticalsSNDX

$0—

Bicara TherapeuticsBCAX

$0—

Cullinan Therapeutics, Inc.CGEM

$0—

Inhibrx Biosciences, Inc.INBX

$0—

Other financials

Income statement

See full

Operating income-$42.0M-31.9%

Net income-$39.3M-39.6%

EPS (diluted)-$0.64-36.2%

Balance sheet

See full

Cash & equivalents$85.0M-15.7%

Total debt$5.7M-6.9%

Total equity$387.6M+19.8%

Total assets$412.0M+20.0%

Cash flow

See full

Operating cash flow-$32.6M-27.9%

CapEx$88.0K+529%

Free cash flow-$32.7M-28.2%

Valuation

See full

Market cap$1.81B+318%

Enterprise value$1.73B+397%

Returns & leverage

See full

Return on equity-36.9%+21.1pp

Debt / equity0×0.0×

Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s preferred stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s preferred stock?: Tyra Biosciences, Inc. (TYRA) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?: Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.